Business Insurance

Login  |  Register Subscribe



Athersys to ask Nasdaq for another reprieve on delisting its stock

Cleveland regenerative medicine startup has been restructuring to cut costs since mid-2022 while raising money to complete clinical trials of its MultiStem adult stem cell therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance Webinars & Webcasts

August 12: "Get Retrofit: Insurance Savings from Property Upgrades"

August 7: "Friends & Foes: Best Practices for Social Media Risk Management"

August 17: "Supply Chain Crisis?Navigating Business Interruption Coverage and Claims After the Japanese Earthquakes"

September 8: "Dormant Dangers: Protecting Key Corporate Assets from Cyber Attacks"

View all webcasts & webinars


Business Insurance Upcoming Issues

Aug. 22/29: Industry Financials: First-Half Results
Health Care Reform: Impact on Firms

September 5: Special Report: Alternative Risks

September 12: Workers Comp & Safety Management

View editorial calendar
Subscribe to Business Insurance